Provider Confidence and Perceived Barriers when Recommending the Human Papillomavirus Vaccine to Parents
- PMID: 36737584
- DOI: 10.1007/s13187-022-02248-7
Provider Confidence and Perceived Barriers when Recommending the Human Papillomavirus Vaccine to Parents
Abstract
Provider recommendation for the HPV vaccine is considered a critical determinant of vaccine uptake compared to other interventions such as parent education. However, providers cite continued barriers to discuss the vaccines with parents including sexual concerns and other misconceptions. The purpose of this mixed methods study was to evaluate physician knowledge and comfort discussing the vaccine with parents and perceived barriers to vaccine uptake among pediatric residents and attending physicians at a university-affiliated county health clinic. Physicians completed surveys guided by HPV Roundtable information to assess HPV vaccine knowledge, comfortability, and parental barriers to administration. A total of 28 pediatric physicians (20 residents and 8 attendings) completed the survey. HPV vaccine knowledge was high among providers in this study, with 75% of providers reporting high confidence. The majority of physicians in this study reported being comfortable or very comfortable talking to parents about the HPV vaccine (82.1%), recommending the HPV vaccine (89.3%), and recommending the HPV vaccine specifically to hesitant parents (82.1%). Attendings were more comfortable than residents talking to (p = .009) and recommending the vaccine to parents (p = .002). However, physicians reported parents' sexual concerns, vaccine safety, and misconceptions as the predominant barriers. These findings suggest that persistent stigma about the HPV vaccine as prevention for sexually transmitted infection, rather than the HPV vaccine as cancer prevention persist. Findings from this study suggest the need for HPV vaccine education for parents and provider training on targeted communication strategies.
Keywords: Barriers; HPV vaccine; Health communication; Knowledge; Medical education.
© 2023. The Author(s) under exclusive licence to American Association for Cancer Education.
Similar articles
-
Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.Vaccine. 2019 Feb 28;37(10):1307-1312. doi: 10.1016/j.vaccine.2019.01.051. Epub 2019 Feb 4. Vaccine. 2019. PMID: 30733088 Clinical Trial.
-
Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.Womens Health (Lond). 2024 Jan-Dec;20:17455057241227360. doi: 10.1177/17455057241227360. Womens Health (Lond). 2024. PMID: 38282514 Free PMC article.
-
Providers' Perceptions of Parental Human Papillomavirus Vaccine Hesitancy: Cross-Sectional Study.JMIR Cancer. 2019 Jul 2;5(2):e13832. doi: 10.2196/13832. JMIR Cancer. 2019. PMID: 31267976 Free PMC article.
-
USA dental health providers' role in HPV vaccine communication and HPV-OPC protection: a systematic review.Hum Vaccin Immunother. 2019;15(7-8):1863-1869. doi: 10.1080/21645515.2018.1558690. Epub 2019 Jan 30. Hum Vaccin Immunother. 2019. PMID: 30620632 Free PMC article.
-
Human Papillomavirus Vaccinations: Provider Education to Enhance Vaccine Uptake.Clin Pediatr (Phila). 2023 Sep;62(8):840-848. doi: 10.1177/00099228221147850. Epub 2023 Jan 19. Clin Pediatr (Phila). 2023. PMID: 36655653 Review.
Cited by
-
Human papillomavirus vaccine delivery practices among pediatricians and pediatric trainees in a tertiary hospital in Singapore.Pediatr Discov. 2024 Jul 26;2(3):e102. doi: 10.1002/pdi3.102. eCollection 2024 Sep. Pediatr Discov. 2024. PMID: 40625450 Free PMC article.
-
Strategies, Barriers, and Facilitators for Healthcare Professionals to Recommend HPV Vaccination: A Systematic Review.Vaccines (Basel). 2025 Apr 12;13(4):402. doi: 10.3390/vaccines13040402. Vaccines (Basel). 2025. PMID: 40333298 Free PMC article. Review.
-
Types of HPV Vaccine Misinformation Circulating on Twitter (X) That Parents Find Most Concerning: Insights From a Cross-Sectional Survey and Content Analysis.J Med Internet Res. 2025 May 12;27:e54657. doi: 10.2196/54657. J Med Internet Res. 2025. PMID: 40354114 Free PMC article.
References
-
- Chido-Amajuoyi OG, Jackson I, Yu R, Shete S (2020) Declining awareness of HPV and HPV vaccine within the general US population. Hum Vaccin Immunother 17(2):420–427. https://doi.org/10.1080/21645515.2020.1783952 - DOI - PubMed - PMC
-
- Sriram S, Ranganathan R (2019) Why human papilloma virus vaccination coverage is low among adolescents in the US? A study of barriers for vaccination uptake. J Fam Med Primary Care 8(3):866. https://doi.org/10.4103/jfmpc.jfmpc_107_19 - DOI
-
- Gravitt PE (2011) The known unknowns of HPV natural history. J Clin Invest 121(12):4593–4599. https://doi.org/10.1172/JCI57149 - DOI - PubMed - PMC
-
- Munoz N, Castellsague X, Berrington de Gonzales A, Lutz G (2006) Chapter 1 HPV in the etiology of human cancer. Vaccine 24(3):S1–S10. https://doi.org/10.1016/j.vaccine.2006.05.115 - DOI
-
- Centers for Disease Control and Prevention. Cancers Associated with Human Papillomavirus, United States—2014–2018. USCS Data Brief, no. 26. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources